We are using cookies This website uses cookies in order to offer you the most relevant information. By browsing this website, you accept these cookies.
Different treatment strategies need to be developed for both T1a BC and T1b BC.
2
Conclusions: There is an association between AST and improved RFS or OAS for breast cancer patients with T1a tumors.
3
Retrospective studies suggest that HER2-neu status is a powerful independent prognostic factor in T1a,b node-negative breast cancer.
4
From this group, we retrospectively identified 29 men with clinical stage T1a and 83 with clinical stage T1b disease.
5
For T1a GB cancer, the optimal treatment modality is simple cholecystectomy, which can be carried out as either a laparotomy or a laparoscopic surgery.
6
The prognosis of these patients with stage T1aN0M0 or T1bN0M0 disease is good enough that adjuvant chemotherapy cannot improve it further.
7
The usefulness of the current TNM staging system can be improved by subdividing T1 tumors into T1a (4 cm.
8
The one patient with a non-fluorescent tumor had a T1a tumor with two 0.4 cm tumor foci within a larger polyp.
9
Consensus guidelines state that the prognosis of patients with T1a that are N0 is uncertain even if HER2 is amplified or overexpressed.
10
Performance: According to the results of controlled (non-randomized) trials on T1a renal cell cancer, the cancer-specific survival rates are comparable between ablative and surgical techniques.
11
Materials and methods: From June 2010 to December 2012, 54 consecutive patients with T1a-T1b renal tumour were enrolled in a high-volume tertiary institution.
12
Patients who received chemotherapy did not have significantly better BCSS or OS than those who did not receive chemotherapy for stage T1aN0M0 or T1bN0M0 disease.